[Parapneumonic effusion and empyema].
The infectious effusion, one of the most frequent causes of pleural effusions in the clinical practice, is a sign of complication of the pneumonic disease. The early recognition of the parapneumonic effusion is crucial to determine the best treatment form and reduce the risk of morbidity and mortality. The evolution in the diagnostic methods and the contribution of several studies published in the literature allowed to establish evidence-based guidelines that are used to guide the treatment of the parapneumonic pleural effusion and empyema.
Marchi
Evaldo
E
Faculdade de Medicina Universidade de São Paulo, São Paulo, SP, Brazil.
Lundgren
Fernando
F
Mussi
Ricardo
R
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D017714:Community-Acquired Infections / Q000150:complications; D003428:Cross Infection / Q000150:complications; D004322:Drainage; D016724:Empyema, Pleural / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D019317:Evidence-Based Medicine; D006801:Humans; D019152:Paracentesis; D010996:Pleural Effusion / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D018410:Pneumonia, Bacterial / Q000150:complications*; D012307:Risk Factors; D012720:Severity of Illness Index; D015912:Thrombolytic Therapy
D000900:Anti-Bacterial Agents